Françoise Kraeber-Bodere
Nuclear medicine physician and researcher involved in the CASSIOPET ancillary study, reporting on prognostic value of pre-maintenance FDG PET/CT in newly diagnosed multiple myeloma.
Best podcasts with Françoise Kraeber-Bodere
Ranked by the Snipd community
Dec 18, 2025 • 20min
Novel Differentiation Therapies for AML and Prognostic Value of PET in MM
Vijay Sankaran, a physician-scientist in hematology research, Ruud Delwel, a leukemia biology expert, and Françoise Kraeber-Bodere, a nuclear medicine physician, delve into groundbreaking studies on the MECOM gene's impact on acute myeloid leukemia therapies. They explore how MECOM repression might enhance CEBPA expression to promote differentiation in leukemias. Also discussed are the promising results from the CASSIOPET study showing that pre-maintenance PET negativity is a strong prognostic indicator for multiple myeloma outcomes.
